Table 1.

Scope of guidelines on HDP and CVD in pregnancy.

PUBLISHER	TYPE OF PUBLISHER	CLINICAL CONDITION FOCUSED	STAGE OF PREGNANCY FOCUSED	AIM OF THE GUIDELINE RECOMMENDATIONS (PREVENTION/SCREENING/MANAGEMENT)
WHO (19,20,21,22,23,24,25)	WHO	Preeclampsia, Hypertension	Preconception; Antenatal	Prevention; Management
ESC (4)	IPO	CVD	Preconception; Antenatal; Intrapartum; and Postpartum	Prevention; Screening; Management
FIGO (26)	IPO	Preeclampsia	Antenatal	Prevention; Screening
ISSHP (27)	IPO	HDP	Antenatal; Intrapartum; Postpartum and long-term follow-up	Prevention; Screening; Management
MOH, Malaysia (28)	MOH	CVD	Preconception; Antenatal; Intrapartum; Postpartum and long-term follow-up	Prevention; Screening; Management
MOH, Peru (30)	MOH	HDP	Antenatal; Intrapartum	Prevention; Management
MOH, South Africa (29)	MOH	HDP	Antenatal; Intrapartum; Postpartum and long-term follow-up	Prevention; Screening; Management
BCS, Brazil (32)	NPO	CVD	Preconception; Antenatal; Intrapartum and Postpartum	Prevention; Screening; Management
CMA, China (31)	NPO	HDP	Preconception; Antenatal; Intrapartum; Postpartum and long-term follow-up	Prevention; Screening; Management
SLCOG, Sri Lanka (34)	NPO	HDP	Preconception; Antenatal; Intrapartum and Postpartum	Prevention; Screening; Management
SOGP, Pakistan (33)	NPO	HDP	Preconception; Antenatal; Intrapartum; Postpartum and long-term follow-up	Prevention; Screening; Management

CVD, cardiovascular diseases; HDP, hypertensive diseases of pregnancy.

WHO, World Health Organization; ESC, European Society of Cardiology; FIGO, The International Federation of Gynaecology and Obstetrics; ISSHP, International Society for the Study of Hypertension in Pregnancy; MOH, Ministry of Health; BCS, Brazilian Cardiology Society; CMA, Chinese Medical Association; SLCOG, Sri Lanka College of Obstetricians and Gynaecologists; SOGP, Society of Obstetricians and Gynaecologists Pakistan.